Get started
Author

Klaus Goldhahn

Observed names: Goldhahn, Klaus, K. Goldhahn
ORCID: 0000-0002-6936-596X
Observed ORCID: 0000-0002-6936-596X
OpenAlex ID: A5007897358
The prevalence of food allergy: A meta-analysis
2007 · Roberto J. Rona, Thomas Keil, et al. · Journal of Allergy and Clinical Immunology · 1,371
The prevalence of plant food allergies: A systematic review
2008 · Laurian Zuidmeer, Klaus Goldhahn, et al. · Journal of Allergy and Clinical Immunology · 495
PDF
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial
2024 · Oliver Schwartz, Katharina Vill, et al. · Archives of Pediatrics and Adolescent Medicine · 84
PDF
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy
2022 · Astrid Pechmann, Max Behrens, et al. · Brain · 81
PDF
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study
2024 · Claudia Weiß, Lena-Luise Becker, et al. · The Lancet Regional Health - Europe · 38
Glial and neuronal damage markers in patients with anorexia nervosa
2008 · Stefan Ehrlich, Roland Burghardt, et al. · Journal of Neural Transmission · 34
WWOXdevelopmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk
2023 · Karen L. Oliver, Marina Trivisano, et al. · Epilepsia · 26
PDF
Sex-specific differences in allergic sensitization to house dust mites: a meta-analysis
2009 · Klaus Goldhahn, Angelina Bockelbrink, et al. · Annals of Allergy Asthma & Immunology · 24
S100B in underweight and weight-recovered patients with anorexia nervosa
2008 · Stefan Ehrlich, Harriet Salbach-Andrae, et al. · Psychoneuroendocrinology · 20
Closing the Gap - Detection of 5q-Spinal Muscular Atrophy by Short-Read Next-Generation Sequencing and Unexpected Results in a Diagnostic Patient Cohort
2023 · Stephanie Kleinle, Veronika Scholz, et al. · Journal of Neuromuscular Diseases · 9
PDF
Use of Sodium Channel Blockers in the Thr226Met Pathologic Variant of SCN1A: A Case Report
2023 · Brenda Carolina Nájera-Chávez, Lea Seeber, et al. · Neuropediatrics · 6
PDF
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland—part I—systematic literature review and existing evidence
2025 · Claudia Weiß, Katharina Vill, et al. · Journal of Neuromuscular Diseases · 5
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry
2025 · Cornelia Voigt-Müller, Michelle Pfaffenlehner, et al. · Brain · 3
PDF
Real-World Data for Onasemnogen Abeparvovec (Zolgensma) in Spinal Muscular Atrophy
2021 · C. Weiß, A. Ziegler, et al. · Neuropediatrics · 2
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland – part II – expert based recommendations for surveillance and management of side-effects
2026 · Andreas Ziegler, Claudia Weiß, et al. · Journal of Neuromuscular Diseases · 1
Risdiplam Add‐On Therapy Following Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy and 2 SMN2 Copies: A Multi‐Center Case Series
2026 · Corinna Stoltenburg, Klaus Goldhahn, et al. · Muscle & Nerve · 1
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence
2026 · Weiss, Claudia, Vill, Katharina, et al. · Zurich Open Repository and Archive (University of Zurich)
Real-World Data on the Efficacy of Gene Replacement Therapy for Spinal Muscular Atrophy (SMA)
2023 · C. Weiß, L.-L. Becker, et al. · Neuropediatrics
Neurological Soft Signs bei Patientinnen mit Anorexia nervosa
2009 · Goldhahn, Klaus · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
Works count: 20
Citation count: 2,201
H-index: 9
I10-index: 9
Year
Topic
Type